How Does SGD Pharma Envision the Future of the Pharma/Biopharma Industry?
Source: Pharma's Almanac - December 2020
SGD Pharma, one of That's Nice's Road to 2021 sponsors, discusses how the company is envisioning the future of the pharma/biopharma industry.
The industry will certainly change over the coming decade, with several trends structurally modifying how people are cared for and how manufacturing is conducted. The pandemic is accelerating multiple existing trends.
One such example is the switch to ready-to-use (RTU) vials: this trend began over the last decade in vials, but demand has significantly increased during the last six months for vaccines, while bulk filling is becoming obsolete, even for high volumes.
Packaging materials, especially tubular glass vials, are becoming scarce, driving adoption of complementary alternatives, such as molded glass vials, which offer higher chemical and physical characteristics.
The pandemic has also increased needs for home care, which has driven demand for diagnostic facilities, which need to be closer to populations for testing, as well as online medical consulting. Packaging strength is thus becoming increasingly important, as are innovations that facilitate ease of use.
Read the full article here